NCT06370871 2024-07-17
Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma
Boehringer Ingelheim
Phase 3 Withdrawn
Boehringer Ingelheim
Agenus Inc.
Emory University
Pfizer
Spectrum Pharmaceuticals, Inc
SWOG Cancer Research Network
Stanford University